<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37520724</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-0042</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>18</Day></PubDate></JournalIssue><Title>iScience</Title><ISOAbbreviation>iScience</ISOAbbreviation></Journal><ArticleTitle>Extracellular vesicles in COVID-19 convalescence can regulate T&#xa0;cell metabolism and function.</ArticleTitle><Pagination><StartPage>107280</StartPage><MedlinePgn>107280</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">107280</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.isci.2023.107280</ELocationID><Abstract><AbstractText>Long-term T&#xa0;cell dysregulation has been reported following COVID-19 disease. Prolonged T&#xa0;cell activation is associated with disease severity and may be implicated in producing long-covid symptoms. Here, we assess the role of extracellular vesicles (EV) in regulating T&#xa0;cell function over several weeks post COVID-19 disease. We find that alterations in cellular origin and protein content of EV in COVID-19 convalescence are linked to initial disease severity. We demonstrate that convalescent donor-derived EV can alter the function and metabolic rewiring of CD4 and CD8 T&#xa0;cells. Of note, EV following mild, but not severe disease, show distinctly immune-suppressive properties, reducing T&#xa0;cell effector cytokine production and glucose metabolism. Mechanistically our data indicate the involvement of EV-surface ICAM-1 in facilitating EV-T cell interaction. Our data demonstrate that circulatory EV are phenotypically and functionally altered several weeks following acute infection, suggesting a role for EV as long-term immune modulators.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>George</LastName><ForeName>Molly S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Jenifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rollings</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Scotland DD1 5EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fear</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irving</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Guy's and St Thomas' Hospital, London SE1 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinclair</LastName><ForeName>Linda V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Scotland DD1 5EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schurich</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London SE1 9RT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>COV/DUN/20/01</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>iScience</MedlineTA><NlmUniqueID>101724038</NlmUniqueID><ISSNLinking>2589-0042</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">Virology</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>4</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37520724</ArticleId><ArticleId IdType="pmc">PMC10371842</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2023.107280</ArticleId><ArticleId IdType="pii">S2589-0042(23)01357-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moss, P. The T Cell Immune Response against SARS-CoV-2. 10.1038/s41590-021-01122-w</Citation><ArticleIdList><ArticleId IdType="pubmed">35105982</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T., Perez-Potti A., Rivera-Ballesteros O., Str&#xe5;lin K., Gorin J.-B., Olsson A., Llewellyn-Lacey S., Kamal H., Bogdanovic G., Muschiol S., et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020;183:158&#x2013;168.e14. doi: 10.1016/j.cell.2020.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7427556</ArticleId><ArticleId IdType="pubmed">32979941</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M., Chroscicki P., Swatler J., Stepnik D., de Biasi S., Hampel M., Brewinska-Olchowik M., Maliszewska A., Sklinda K., Durlik M., et al. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection. Front. Immunol. 2022;13:886431. doi: 10.3389/fimmu.2022.886431.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa H.A., Shaw T.N., Knight S.B., Wemyss K., McClure F.A., Pearmain L., Prise I., Jagger C., Morgan D.J., Khan S., et al. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med. 2021;2:720&#x2013;735.e4. doi: 10.1016/J.MEDJ.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MEDJ.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B., Lim E., Mactavous L., Jackson S., Team N.B.T.N.B., Lyons P., Doffinger R., Bradley J., Smith K., Sinclair J., et al. Spontaneous, persistent T-cell dependent IFN-&#x3b3; release in patients who progress to Long COVID. PREPRINT, Research Square. 2022 doi: 10.21203/rs.3.rs-2034285/v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-2034285/v2</ArticleId><ArticleId IdType="pmc">PMC10881041</ArticleId><ArticleId IdType="pubmed">38381822</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangaev A., Ketelaars S.L.C., Isaeva O.I., Patiwael S., Dopler A., Hoefakker K., de Biasi S., Gibellini L., Mussini C., Guaraldi G., et al. Identification and characterization of a SARS-CoV-2 specific CD8+ T&#xa0;cell response with immunodominant features. Nat. Commun. 2021;12:2593. doi: 10.1038/s41467-021-22811-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22811-y</ArticleId><ArticleId IdType="pmc">PMC8110804</ArticleId><ArticleId IdType="pubmed">33972535</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J.K., Boppana S., Perez M.D., Sarkar S., Lowman K.E., Qin K., Sterrett S., Carlin E., Bansal A., Sabbaj S., et al. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. J.&#xa0;Clin. Invest. 2021;131:e140491. doi: 10.1172/JCI140491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140491</ArticleId><ArticleId IdType="pmc">PMC7773371</ArticleId><ArticleId IdType="pubmed">33119547</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzas E.I. The roles of extracellular vesicles in the immune system. Nat. Rev. Immunol. 2023;23:236&#x2013;250. doi: 10.1038/s41577-022-00763-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00763-8</ArticleId><ArticleId IdType="pmc">PMC9361922</ArticleId><ArticleId IdType="pubmed">35927511</ArticleId></ArticleIdList></Reference><Reference><Citation>Barros F.M., Carneiro F., Machado J.C., Melo S.A. Exosomes and Immune Response in Cancer: Friends or Foes? Front. Immunol. 2018;9:730. doi: 10.3389/fimmu.2018.00730.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00730</ArticleId><ArticleId IdType="pmc">PMC5904196</ArticleId><ArticleId IdType="pubmed">29696022</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Martin R., Brandao B.B., Thomou T., Altindis E., Kahn C.R. Tissue differences in the exosomal/small extracellular vesicle proteome and their potential as indicators of altered tissue metabolism. Cell Rep. 2022;38:110277. doi: 10.1016/j.celrep.2021.110277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110277</ArticleId><ArticleId IdType="pmc">PMC8867597</ArticleId><ArticleId IdType="pubmed">35045290</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P., Diergaarde B., Ferrone S., Kirkwood J.M., Whiteside T.L. Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells. Sci. Rep. 2020;10:92. doi: 10.1038/s41598-019-56542-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56542-4</ArticleId><ArticleId IdType="pmc">PMC6952363</ArticleId><ArticleId IdType="pubmed">31919420</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside T.L. Exosomes carrying immunoinhibitory proteins and their role in cancer. Clin. Exp. Immunol. 2017;189:259&#x2013;267. doi: 10.1111/cei.12974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12974</ArticleId><ArticleId IdType="pmc">PMC5543496</ArticleId><ArticleId IdType="pubmed">28369805</ArticleId></ArticleIdList></Reference><Reference><Citation>Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., Ricciardi-Castagnoli P., Raposo G., Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat. Med. 1998;4:594&#x2013;600. doi: 10.1038/nm0598-594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0598-594</ArticleId><ArticleId IdType="pubmed">9585234</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E., Vanella V.v., Falasca M., Caneapero V., Cappellano G., Raineri D., Ghirimoldi M., de Giorgis V., Puricelli C., Vaschetto R., et al. Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection. Front. Mol. Biosci. 2021;8:29. doi: 10.3389/FMOLB.2021.632290/BIBTEX.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMOLB.2021.632290/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC7937875</ArticleId><ArticleId IdType="pubmed">33693030</ArticleId></ArticleIdList></Reference><Reference><Citation>Balbi C., Burrello J., Bolis S., Lazzarini E., Biemmi V., Pianezzi E., Burrello A., Caporali E., Grazioli L.G., Martinetti G., et al. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection. EBioMedicine. 2021;67:103369. doi: 10.1016/J.EBIOM.2021.103369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2021.103369</ArticleId><ArticleId IdType="pmc">PMC8104913</ArticleId><ArticleId IdType="pubmed">33971404</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrello J., Caporali E., Gauthier L.G., Pianezzi E., Balbi C., Rigamonti E., Bolis S., Lazzarini E., Biemmi V., Burrello A., et al. Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles. Vascul. Pharmacol. 2022;145:106999. doi: 10.1016/J.VPH.2022.106999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.VPH.2022.106999</ArticleId><ArticleId IdType="pmc">PMC9116046</ArticleId><ArticleId IdType="pubmed">35597450</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta&#x15f;l&#x131; N.P., G&#xf6;nen Z.B., K&#x131;rba&#x15f; O.K., G&#xf6;kdemir N.S., Bozkurt B.T., Bayrakc&#x131; B., Sa&#x11f;ra&#xe7; D., Ta&#x15f;kan E., Demir S., Ekimci G&#xfc;rcan N., et al. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2. Front. Immunol. 2022;13:824378. doi: 10.3389/FIMMU.2022.824378/FULL.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2022.824378/FULL</ArticleId><ArticleId IdType="pmc">PMC8987587</ArticleId><ArticleId IdType="pubmed">35401544</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamachary B., Cook C., Kumar A., Spikes L., Chalise P., Dhillon N.K. Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity. J.&#xa0;Extracell. Vesicles. 2021;10:e12117. doi: 10.1002/JEV2.12117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JEV2.12117</ArticleId><ArticleId IdType="pmc">PMC8254805</ArticleId><ArticleId IdType="pubmed">34262673</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosell A., Havervall S., von Meijenfeldt F., Hisada Y., Aguilera K., Grover S.P., Lisman T., Mackman N., Th&#xe5;lin C. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality&#x2014;Brief Report. Arterioscler. Thromb. Vasc. Biol. 2021;41:878&#x2013;882. doi: 10.1161/ATVBAHA.120.315547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315547</ArticleId><ArticleId IdType="pmc">PMC7837685</ArticleId><ArticleId IdType="pubmed">33267656</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y., Hoshina T., Matsuzaki J., Yoshioka Y., Kadota T., Hosaka Y., Fujimoto S., Kawamoto H., Watanabe N., Sawaki K., et al. Early prediction of COVID-19 severity using extracellular vesicle COPB2. J.&#xa0;Extracell. Vesicles. 2021;10:e12092. doi: 10.1002/JEV2.12092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JEV2.12092</ArticleId><ArticleId IdType="pmc">PMC8172627</ArticleId><ArticleId IdType="pubmed">34122778</ArticleId></ArticleIdList></Reference><Reference><Citation>Koliha N., Wiencek Y., Heider U., J&#xfc;ngst C., Kladt N., Krauth&#xe4;user S., Johnston I.C.D., Bosio A., Schauss A., Wild S. A novel multiplex bead-based platform highlights the diversity of extracellular vesicles. J.&#xa0;Extracell. Vesicles. 2016;5:29975. doi: 10.3402/jev.v5.29975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v5.29975</ArticleId><ArticleId IdType="pmc">PMC4762227</ArticleId><ArticleId IdType="pubmed">26901056</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu T., Ning W., Wu D., Xu J., Han Q., Huang M., Zou X., Yang Q., Yuan Y., Bie Y., et al. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19. Immunity. 2020;53:1108&#x2013;1122.e5. doi: 10.1016/j.immuni.2020.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.10.008</ArticleId><ArticleId IdType="pmc">PMC7574896</ArticleId><ArticleId IdType="pubmed">33128875</ArticleId></ArticleIdList></Reference><Reference><Citation>Saferali A., Tang A.C., Strug L.J., Quon B.S., Zlosnik J., Sandford A.J., Turvey S.E. Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1. PLoS One. 2020;15:e0227067. doi: 10.1371/journal.pone.0227067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0227067</ArticleId><ArticleId IdType="pmc">PMC6957340</ArticleId><ArticleId IdType="pubmed">31931521</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao G., Zhang H.M., Qiu Y., Ye X., Yang D. Cleavage of Desmosomal Cadherins Promotes &#x3b3;-Catenin Degradation and Benefits Wnt Signaling in Coxsackievirus B3-Induced Destruction of Cardiomyocytes. Front. Microbiol. 2020;11:767. doi: 10.3389/fmicb.2020.00767.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00767</ArticleId><ArticleId IdType="pmc">PMC7225294</ArticleId><ArticleId IdType="pubmed">32457708</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuai X., Wei-min L., Tong Y.L., Dong N., Sheng Z.Y., Yao Y.M. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T&#xa0;cells. Sci. Rep. 2015;5:14478. doi: 10.1038/srep14478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14478</ArticleId><ArticleId IdType="pmc">PMC4585986</ArticleId><ArticleId IdType="pubmed">26411375</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Li Y., Guo C., Wang L., Chu H., Zhu F., Li Y., Wang X., Wang Q., Zhao W., et al. IL-37 isoform D downregulates pro-inflammatory cytokines expression in a Smad3-dependent manner. Cell Death Dis. 2018;9:582. doi: 10.1038/s41419-018-0664-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0664-0</ArticleId><ArticleId IdType="pmc">PMC5964144</ArticleId><ArticleId IdType="pubmed">29789615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., John Wherry E. T cell responses in patients with COVID-19. Nat. Rev. Immunol. 2020;20:529&#x2013;536. doi: 10.1038/s41577-020-0402-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0402-6</ArticleId><ArticleId IdType="pmc">PMC7389156</ArticleId><ArticleId IdType="pubmed">32728222</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez J., Jackson I., Flaherty K.R., Muliaditan T., Schurich A. Divergent impact of glucose availability on human virus-specific and generically activated CD8 T&#xa0;cells. Metabolites. 2020;10:461. doi: 10.3390/metabo10110461.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo10110461</ArticleId><ArticleId IdType="pmc">PMC7696163</ArticleId><ArticleId IdType="pubmed">33202938</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurich A., Pallett L.J., Jajbhay D., Wijngaarden J., Otano I., Gill U.S., Hansi N., Kennedy P.T., Nastouli E., Gilson R., et al. Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8&#xa0;T Cells in the Same Host. Cell Rep. 2016;16:1243&#x2013;1252. doi: 10.1016/j.celrep.2016.06.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.06.078</ArticleId><ArticleId IdType="pmc">PMC4977274</ArticleId><ArticleId IdType="pubmed">27452473</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck M.D., Sowell R.T., Kaech S.M., Pearce E.L. Metabolic Instruction of Immunity. Cell. 2017;169:570&#x2013;586. doi: 10.1016/j.cell.2017.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.04.004</ArticleId><ArticleId IdType="pmc">PMC5648021</ArticleId><ArticleId IdType="pubmed">28475890</ArticleId></ArticleIdList></Reference><Reference><Citation>Arg&#xfc;ello R.J., Combes A.J., Char R., Gigan J.P., Baaziz A.I., Bousiquot E., Camosseto V., Samad B., Tsui J., Yan P., et al. SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution. Cell Metab. 2020;32:1063&#x2013;1075.e7. doi: 10.1016/j.cmet.2020.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.11.007</ArticleId><ArticleId IdType="pmc">PMC8407169</ArticleId><ArticleId IdType="pubmed">33264598</ArticleId></ArticleIdList></Reference><Reference><Citation>Puleston D. Detection of mitochondrial mass, damage, and reactive oxygen species by flow cytometry. Cold Spring Harb. Protoc. 2015;2015 doi: 10.1101/pdb.prot086298. pdb.prot086298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/pdb.prot086298</ArticleId><ArticleId IdType="pubmed">26330624</ArticleId></ArticleIdList></Reference><Reference><Citation>Swadling L., Pallett L.J., Diniz M.O., Baker J.M., Amin O.E., Stegmann K.A., Burton A.R., Schmidt N.M., Jeffery-Smith A., Zakeri N., et al. Human Liver Memory CD8+ T Cells Use Autophagy for Tissue Residence. Cell Rep. 2020;30:687&#x2013;698.e6. doi: 10.1016/j.celrep.2019.12.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.12.050</ArticleId><ArticleId IdType="pmc">PMC6988113</ArticleId><ArticleId IdType="pubmed">31968246</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolte-&#x2019;t Hoen E.N.M., Buschow S.I., Anderton S.M., Stoorvogel W., Wauben M.H.M. Activated T Cells Recruit Exosomes Secreted by Dendritic Cells via LFA-1. Blood. 2009;113:1977&#x2013;1981. doi: 10.1182/blood.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood</ArticleId><ArticleId IdType="pubmed">19064723</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchard N., Lankar D., Faure F., Regnault A., Dumont C., Raposo G., Hivroz C. TCR Activation of Human T Cells Induces the Production of Exosomes Bearing the TCR/CD3/&#x3b6; Complex. J.&#xa0;Immunol. 2002;168:3235&#x2013;3241. doi: 10.4049/jimmunol.168.7.3235.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.7.3235</ArticleId><ArticleId IdType="pubmed">11907077</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing A.G., Lorenc A., del Molino del Barrio I., Das A., Fish M., Monin L., Mu&#xf1;oz-Ruiz M., McKenzie D.R., Hayday T.S., Francos-Quijorna I., et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat. Med. 2020;26:1623&#x2013;1635. doi: 10.1038/s41591-020-1038-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1038-6</ArticleId><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsuyama Y., Yamakawa K., Kayano K., Maruyama M., Wada T., Fujimi S. Prolonged enhancement of cytotoxic T lymphocytes in the post-recovery state of severe COVID-19. J.&#xa0;Intensive Care. 2021;9:76. doi: 10.1186/S40560-021-00591-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S40560-021-00591-3</ArticleId><ArticleId IdType="pmc">PMC8685802</ArticleId><ArticleId IdType="pubmed">34930468</ArticleId></ArticleIdList></Reference><Reference><Citation>Suades R., Padr&#xf3; T., Vilahur G., Badimon L. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb. Haemost. 2012;108:1208&#x2013;1219. doi: 10.1160/TH12-07-0486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH12-07-0486</ArticleId><ArticleId IdType="pubmed">23138460</ArticleId></ArticleIdList></Reference><Reference><Citation>Katneni U.K., Alexaki A., Hunt R.C., Schiller T., Dicuccio M., Buehler P.W., Ibla J.C., Kimchi-Sarfaty C. Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus. Thromb. Haemost. 2020;120:1668&#x2013;1679. doi: 10.1055/s-0040-1715841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715841</ArticleId><ArticleId IdType="pmc">PMC7869056</ArticleId><ArticleId IdType="pubmed">32838472</ArticleId></ArticleIdList></Reference><Reference><Citation>Njock M.S., Cheng H.S., Dang L.T., Nazari-Jahantigh M., Lau A.C., Boudreau E., Roufaiel M., Cybulsky M.I., Schober A., Fish J.E. Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs. Blood. 2015;125:3202&#x2013;3212. doi: 10.1182/blood-2014-11-611046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-11-611046</ArticleId><ArticleId IdType="pmc">PMC4440888</ArticleId><ArticleId IdType="pubmed">25838349</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovanoski N., Chen X., Becker U., Zalocusky K., Chawla D., Tsai L., Borm M., Neighbors M., Yau V. Severity of COVID-19 and adverse long-term outcomes: a retrospective cohort study based on a US electronic health record database. BMJ Open. 2021;11:e056284. doi: 10.1136/BMJOPEN-2021-056284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJOPEN-2021-056284</ArticleId><ArticleId IdType="pmc">PMC9065767</ArticleId><ArticleId IdType="pubmed">34893488</ArticleId></ArticleIdList></Reference><Reference><Citation>Metsalu T., Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res. 2015;43:W566&#x2013;W570. doi: 10.1093/nar/gkv468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv468</ArticleId><ArticleId IdType="pmc">PMC4489295</ArticleId><ArticleId IdType="pubmed">25969447</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3.</Citation><ArticleIdList><ArticleId IdType="pubmed">12734009</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y., Bai J., Bandla C., Garc&#xed;a-Seisdedos D., Hewapathirana S., Kamatchinathan S., Kundu D.J., Prakash A., Frericks-Zipper A., Eisenacher M., et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543&#x2013;D552. doi: 10.1093/nar/gkab1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1038</ArticleId><ArticleId IdType="pmc">PMC8728295</ArticleId><ArticleId IdType="pubmed">34723319</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>